Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

galpharm international ltd - caffeine; glucose monohydrate - tablet - 30mg ; 150mg

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - letrozole -

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pfizer (malaysia) sdn. bhd. - methotrexate -

Īrija - angļu - HPRA (Health Products Regulatory Authority)

brillpharma (ireland) limited - paracetamol; anhydrous caffeine - tablet - 500/65 mg/mg - anilides; paracetamol, combinations excl. psycholeptics

Īrija - angļu - HPRA (Health Products Regulatory Authority)

chefaro ireland dac - paracetamol; caffeine - tablet - 500 mg/65 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methotrexate 25 mg/ml (as methotrexate sodium) - solution for injection - 7.5 mg/0.3ml - active: methotrexate 25 mg/ml (as methotrexate sodium) excipient: sodium chloride sodium hydroxide water for injection - methotrexate may be of value in the symptomatic control of server, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, methotrexate should be used after the diagnosis has been definitely established, as by biopsy and/or after dermatologic consultation.

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pfizer (malaysia) sdn. bhd. - methotrexate -

Dienvidāfrikas Republika - angļu - South African Health Products Regulatory Authority (SAHPRA)

smart pharmaceuticals (pty) ltd - tablet - not indicated - none

Kanāda - angļu - Health Canada

novartis pharmaceuticals canada inc - letrozole - tablet - 2.5mg - letrozole 2.5mg - antineoplastic agents